Top Markets
Coin of the day
Glenmark Life Sciences Limited Glenmark Life Sciences Limited

Glenmark Life Sciences Limited

GLS
Rang in aandelen #7700
Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011,... Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011, specializes in the creation, manufacturing, and distribution of high-value active pharmaceutical ingredients (APIs). These APIs are utilized across a wide array of chronic therapeutic areas. The company's diverse portfolio includes compounds for managing cardiovascular diseases (e.g., Olmesartan, Rosuvastatin, Amiodarone), central nervous system conditions (such as Oxcarbazepine, Topiramate, Lacosamide), and diabetes (including Glimepiride, Teneligliptin, Linagliptin). Additionally, they produce APIs for pain management (Etoricoxib, Lornoxicam), gastro-intestinal disorders, anti-infective treatments, respiratory ailments, and anti-emetic applications, featuring products like Atovaquone, Fluconazole, and Esomeprazole Magnesium. Beyond API production, Glenmark Life Sciences offers contract development and manufacturing (CDMO) solutions to numerous multinational and specialty pharmaceutical firms. Operating as a subsidiary of Glenmark Pharmaceuticals Limited, the company exports its products worldwide, reaching markets in Europe, North America, Latin America, and Japan.
Aandeelprijs
$12.18
Laatst gesynchroniseerd: 2025-02-17
Marktkapitalisatie
$1.49B
Verandering (1 dag)
4.21%
Verandering (1 jaar)
0.00%
Land
IN
Handel Glenmark Life Sciences Limited (GLS)

Categorie

Aandelsplitsingen voor Glenmark Life Sciences Limited (GLS)
Het aandeel Glenmark Life Sciences Limited (symbool: GLS) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 28, 2026.
Eén aandeel GLS dat vóór Aug 28, 2026 werd gekocht, staat nu gelijk aan 0 aandelen GLS.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten